Health And Medicine

Vanderbilt investigators have identified an unexpected link between cell survival and the polarized delivery of proteins to the surface of mammary epithelial cells. Read More

A new protein structure may guide the development of Alzheimer's therapeutics. Read More

The first large study to report that HIV-infected people have a significantly higher risk of heart failure in the antiretroviral therapy era has been published in JAMA Cardiology. Read More

Vanderbilt investigators are probing the response to a bacterial toxin as a clinical assessment of immune function. Read More

Medicaid expansion under the Affordable Care Act provides patients with a greater choice of hospital facilities, Vanderbilt researchers have found. Read More

Structural details of a protein that removes DNA lesions shed light on fundamental mechanisms of DNA repair. Read More

Vanderbilt investigators have studied the relationship between race, cardiometabolic traits and pulmonary hypertension. Read More

Vanderbilt investigators have developed hospital readmission models that may help prevent payment penalties to hospitals when patients are readmitted too soon after discharge. Read More

John Wilson, Ph.D., assistant professor of Chemical and Biomolecular Engineering and of Biomedical Engineering at Vanderbilt University, has received an Innovative Research Grant from Stand Up To Cancer (SU2C). Wilson is among 10 early-career scientists to receive the grant awards focused on immuno-oncology. Read More

A detailed structural and functional analysis of the yeast protein that is the main target of antifungal drugs will help direct efforts to develop better treatments. Read More

In budding yeast, accumulation of a certain type of RNA in the nucleus increased life span, offering a new clue to longevity. Read More

The 2017 Vanderbilt Symposium on Modeling Immunity will be held from 1 to 4:30 p.m. Thursday, April 27, in room 1220 MRB III. Read More

A novel fluorescent nanobeacon can distinguish normal from diseased colon tissue, potentially offering advantages for colorectal cancer screening. Read More

Despite dramatic recent advances in treatment, colorectal cancer killed more than 49,000 Americans last year, according to the National Cancer Institute, making it the second most lethal malignancy after cancers of the lung and bronchus. Read More

An inhibitor of cell metabolism may be a good therapeutic target for neuroblastoma, which accounts for about 15 percent of pediatric cancer-related deaths. Read More

Interventions for delirium in the emergency department setting are needed to preserve patients’ long-term function and cognition, Vanderbilt investigators have found. Read More

Alumna Kimberly Bryant, founder of Black Girls Code, will discuss the underrepresentation of women in STEM fields with Vanderbilt professors Alyssa Hasty, Bonnie Miller and Nicole Joseph. Read More

Vanderbilt investigators have discovered that activated epidermal growth factor receptor may be a target for therapies to prevent colorectal cancer development. Read More

Researchers at Vanderbilt University Medical Center (VUMC) have mapped the conformational changes that occur in a protein “notorious” for pumping chemotherapeutic drugs out of cancer cells and blocking medications from reaching the central nervous system. Read More

Vanderbilt University Medical Center (VUMC) is one of four centers receiving a $15 million, four-year research award from the American Heart Association (AHA) to provide cutting-edge research on obesity as part of its sixth Strategically Focused Research Network (SFRN). Read More